Zhibo Zhang
Mudanjiang, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Meta-analysis of PD-(L)1 inhibitor plus chemotherapy versus chemotherapy as first-line treatment in extensive-stage small-cell lung cancer.
Journal: Cancer medicine
Published: March 23, 2023
Prognostic value of esophageal cancer immune prognostic index in advanced esophageal squamous cell carcinoma patients with anti-programmed cell death-1 therapy.
Journal: Cancer medicine
Published: January 09, 2023
Prognostic value of plasma D-dimer levels in advanced non-small cell lung cancer patients treated with immune checkpoint inhibitors: a retrospective study.
Journal: Journal of thoracic disease
Published: September 22, 2022
Pretreatment Neutrophil-to-Lymphocyte Ratio as a Prognostic Biomarker in Unresectable or Metastatic Esophageal Cancer Patients With Anti-PD-1 Therapy.
Journal: Frontiers in oncology
Published: December 13, 2021
Decoding the Immune Microenvironment of Clear Cell Renal Cell Carcinoma by Single-Cell Profiling to Aid Immunotherapy.
Journal: Frontiers in immunology
Published: October 08, 2021
Neuron - specific enolase predicts the prognosis in advanced small cell lung cancer patients treated with first-line PD-1/PD-L1 inhibitors.
Journal: Medicine
Published: June 22, 2021
Prognostic value of baseline and change in neutrophil-to-lymphocyte ratio for survival in advanced non-small cell lung cancer patients with poor performance status receiving PD-1 inhibitors.
Journal: Translational lung cancer research
Published: April 23, 2021
Prognostic Value of the Pretreatment Lung Immune Prognostic Index in Advanced Small Cell Lung Cancer Patients Treated With First-Line PD-1/PD-L1 Inhibitors Plus Chemotherapy.
Journal: Frontiers in oncology
Published: April 20, 2021
Immunotherapy beyond progression in patients with advanced non-small cell lung cancer.
Journal: Translational lung cancer research
Published: January 25, 2021
Identification of the Signature Associated With m6A RNA Methylation Regulators and m6A-Related Genes and Construction of the Risk Score for Prognostication in Early-Stage Lung Adenocarcinoma.
Journal: Frontiers in genetics
Published: January 20, 2021
Response Efficacy of PD-1 and PD-L1 Inhibitors in Clinical Trials: A Systematic Review and Meta-Analysis.
Journal: Frontiers in oncology
Published: July 31, 2020
Last Updated: 09/26/2026